Kezar Life Sciences, Inc.
KZR
Revenue
7.00M
▲7.00M∞%
12 Months ChangeAssets
179.92M
▼-19.21M▼-9.65%
3 Months ChangeLiabilities
29.24M
▼-773.00k▼-2.58%
3 Months ChangeFree Cash Flow
-22.86M
▼-1.71M▼-8.06%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0000950170-24-117723
2024-10-17
Form 8-K
ID: 0001193125-24-238562
2024-10-10
Form 8-K
ID: 0000950170-24-113963
2024-10-04
Form 8-K
ID: 0000950170-24-112969
2024-09-30
Form 8-K
ID: 0000950170-24-110177
2024-08-13
Form 10-Q
ID: 0000950170-24-096213
2024-08-13
Form 8-K
ID: 0000950170-24-096165
2024-06-21
Form 8-K
ID: 0000950170-24-076234
2024-06-04
Form 8-K
ID: 0000950170-24-068730
2024-05-09
Form 10-Q
ID: 0000950170-24-056918